Treatment response in chronic urticaria: analysis of clinical and laboratory predictors

Abstract Background Chronic urticaria (CU) compromises quality of life, requiring escalated treatment with second-generation H1 antihistamines, omalizumab, and, in refractory cases, cyclosporine. Predictors of therapeutic response are not yet well established. Objective To evaluate clinical and la...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joice Trigo da Fonseca, Joanemile Pacheco de Figueiredo, Leila Vieira Borges Trancoso Neves, José Carlisson Santos de Oliveira, Janinne Souza de Oliveira, Vitória Rani Figueiredo, Régis de Albuquerque Campos
Format:	Artigo
Idioma:	Inglês
Publicat:	Sociedade Brasileira de Dermatologia 2026-04-01
Col·lecció:	Anais Brasileiros de Dermatologia
Matèries:	Biomarkers Chronic urticaria Histamine antagonists Omalizumab
Accés en línia:	http://www.scielo.br/pdf/abd/v101n1/0365-0596-abd-101-01-501261.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!